Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - OriGene Technologies
 More »

  • Advertorial: OriGene Technologies
    Evolving from a Gene-Based Tool Provider to a Premier Antibody Supplier, for Both Research and Diagnostic Fields OriGene Technologies was founded in 1996 as a research tool company ...
    10-1-2013
  • GEN | Biolinks
    ... Oregon Bioscience Association Oregon Business Development Department Oregon State University Orexigen Therapeutics, Inc ORFLO Technologies/E.I. Spectra Origene OSI Pharmaceuticals, ...
  • OriGene Snaps Up SDIX for $16M
    OriGene Technologies will acquire all assets of life-sciences technology provider SDIX for $16 million, in a deal announced today by both companies. The deal combines SDIX' ...
    4-8-2013
  • Advertorial: OriGene Technologies
    Advancing Its World-Class Collection of cDNA Clones, Human Proteins, Antibodies, and Assays into the Diagnostics Arena OriGene Technologies was founded in 1996 as a research tool ...
    10-1-2012
  • OriGene Takes Over Pathology Reagent Company Zhongshan Golden...
    OriGene Technologies is purchasing Zhongshan Golden Bridge Biotechnology to bolster its position in the Chinese pathology testing market. The Chinese pathology testing market has ...
    3-13-2012
  • Advertorial: OriGene Technologies
    Advancing a World-Class cDNA Clone Collection into the Protein, Antibody, Assay, and Diagnostics Arena OriGene Technologies was founded in 1996 as a research tool company focused ...
    10-1-2011
  • OriGene Picks Up Gene-Synthesis Firm Blue Heron Biotechnology
    OriGene Technologies is acquiring Blue Heron Biotechnology, which has concentrated on gene synthesis since 1999. OriGene believes that coupling Blue Heron's focus with its own ...
    8-13-2010
  • OriGene and ISB to Generate PeptideAtlas and 5,000-Protein SRM...
    OriGene Technologies and the Institute for Systems Biology are pooling their expertise to generate a proteotypic PeptideAtlas and develop a single reaction monitoring, multiple ...
    5-12-2010
  • High-Density Reverse-Phase Protein Arrays
    Solutions available from OriGene Technologies use qPCR methods at the RNA level and high-density tissue lysate RPPA at the protein level. Cancer RPPAs are protein lysates from ...
    4-1-2010
  • OriGene Raises $16M to Create the Largest Collection of mAbs
    OriGene Technologies completed a $16 million Series B financing. The proceeds from the funding will be used to continue building its TrueMAB(tm) monoclonal antibody collection. ...
    3-18-2010
  • OriGene Acquires Marligen to Fortify Gene-Centric Toolbox
    OriGene Technologies is taking over Marligen Biosciences to enhance its gene-centric product portfolio. Marligen adds an array of assay panels and custom assays for drug discovery. ...
    10-20-2009
  • OriGene Secures $6.5M to Set Up mAb Manufacturing Facility in...
    OriGene Technologies raised $6.5 million, which allows it to complete the acquisition of Shenzhen P&A Biotech, a manufacturer and provider of mAbs. With the establishment of this ...
    2-12-2009
  • Researchers Uncover Kinases Involved in Cancer-Related Signaling...
    of Helsinki, VTT Technical Research Centre of Finland, University of Turku, OriGene Technologies, Radboud University Nijmegen. The study is published in the May 2 issue of ...
    5-2-2008
  • Tissue Microarrays Reach New Markets
    Cytomyx (www.cytomyx.com) is expanding applications of its biorepository through a recent collaboration with Origene Technologies (www.origene.com). The biorepository holds more ...
    3-15-2006
  • High Throughput Screening of GPCRs
    ... Comprehensive Clone Set OriGene Technologies (www. origene.com) suggests that there are an estimated 340400 pharmaceutically relevant GPCRs in the human genome. "Identifying and ...
    2-1-2005

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll